首页> 外国专利> Oral microbiota promotion for immune system associated inflammations

Oral microbiota promotion for immune system associated inflammations

机译:口服微生物群促进免疫系统相关炎症

摘要

A method of promoting a desired oral microbiota to treat an inflammation condition related to an allergic reaction in a subject in need of such treatment including providing a preformulated edible composition including an amino acid containing ingredient comprising L-arginine, the composition configured to be present as individual molecules of L-arginine within an oral cavity of the subject; removing a biofilm from surfaces within an oral cavity including exposing the biofilm to a biofilm degrading enzyme; wherein during or following removal of the biofilm, the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 30 seconds to about an hour on a daily basis comprising at least one day to promote an increased concentration of selected oral microbiota, the selected microbiota including Veillonella and Streptococcus.
机译:在需要这种治疗的受试者中促进期望的口腔微生物以治疗与变态反应相关的炎症的方法,该方法包括提供预配制的可食用组合物,该组合物包含包含L-精氨酸的氨基酸成分,该组合物被配置为以受试者口腔内的L-精氨酸的单个分子;从口腔表面去除生物膜,包括使生物膜暴露于生物膜降解酶;其中在去除生物膜的过程中或之后,提供组合物以包含并且至少部分地溶解在受试者的口腔内,持续至少约30秒至约一个小时,基于每天,包括至少一天至一天。促进选定的口腔微生物群(包括 Veillonella 链球菌)的浓度升高。

著录项

  • 公开/公告号US10471033B2

    专利类型

  • 公开/公告日2019-11-12

    原文格式PDF

  • 申请/专利权人 KNOZE JR. CORPORATION;

    申请/专利号US201816001808

  • 发明设计人 SHUNSHENG HAN;

    申请日2018-06-06

  • 分类号A61K31/198;A61K9;A61K35/744;A61K31/7004;A61K31/733;A61K31/719;A61K31/047;A61K38/46;A61K38/48;A61C19/06;A23L33/175;A23L33/125;A23L33/135;A61K38/51;A61K36/725;A61F7;A61K35;

  • 国家 US

  • 入库时间 2022-08-21 11:30:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号